Latest Phage News

Visit Our booth #23 at the 10th AMR Conference on March 3-4 in Basel, Switzerland.

Our team delivers phage services worldwide, drawing on long-term scientific knowledge and expertise. See the phage lab and business environments we work from!

PrecisionPhage is an academically rooted company at the forefront of bacteriophage research and applications. The company's team comprises specialists from Finnish universities and international institutions. Our extensive research portfolio underpins PrecisionPhage's mission to develop high-quality applications for combating antibiotic-resistant infections.

PrecisionPhage was proud to sponsor the ESCMID Global Congress on April 11-15 in Vienna. We welcome you to meet our team members with expertise in modern phage bioinformatics, phage R&D, and phage licensing.

PrecisionPhage was proud to be partnering with the 7th Annual Bacteriophage Therapy Summit on March 11−13 in Boston. Come to hear the expert speech by Olli Pitkänen from PrecisionPhage!

PrecisionPhage has raised €1M in funding from Nordic Science Investment, Genetricum, and Unifund. Additionally, PrecisionPhage has secured €1.2M in Deep Tech Accelerator funding from Business Finland, which will be disbursed in three phases based on the company's performance.

Among 30 competitors, PrecisionPhage rose to the top and won the Tahko Ski Lift Pitch 2024 competition.

Read more about our company and solutions for combating AMR in Finnish media articles.